Back
Aclaris Therapeutics Vs. SoftBank Group Industry Stock Comparison
Sell
46
ACRS
Aclaris Therapeutics
Last Price:
1.19
Seasonality Move:
10.05%
Sell
45
SFTBY
SoftBank Group
Last Price:
29.86
Seasonality Move:
1.61%
Sell
46
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.19. The Score for ACRS is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $29.86. The Score for SFTBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.19
The current trend is relatively stagnant and ACRS is experiencing slight buying pressure.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $29.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 50.98 | Buy |
Chaikin Money Flow: | -76583 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.15 - 1.19) | Buy |
Bollinger Bands (100): | (1.1 - 1.28) | Sell |
SFTBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 53.06 | Buy |
Chaikin Money Flow: | 400281 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.84 - 30.42) | Buy |
Bollinger Bands (100): | (27.1 - 32.74) | Sell |
ACRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Buy |
20-day SMA: | 1.17 | Buy |
50-day SMA: | 1.2 | Sell |
200-day SMA: | 1.19 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.17 | Buy |
50-day EMA: | 1.19 | Sell |
200-day EMA: | 2 | Sell |
SFTBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.89 | Sell |
20-day SMA: | 29.58 | Buy |
50-day SMA: | 28.51 | Buy |
200-day SMA: | 27.85 | Buy |
8-day EMA: | 29.75 | Buy |
20-day EMA: | 29.52 | Buy |
50-day EMA: | 29.38 | Buy |
200-day EMA: | 27.81 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and a decrease next year of $0.09 per share.
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aclaris Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SoftBank Group Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |